Chiron Real Estate Inc.
XRNReal Estate Reit Healthcare Facilities
Chiron Real Estate Inc.’s revenue for fiscal 2025 (year ended December 2025) was $148.2 million, up 6.79% from fiscal 2024.
- Revenue
- +8.34%
- EPS
- n/m
- Free cash flow
- n/m
- Total debt
- −6.76%
Quarter to September 2026, against a year earlier
After hours trading: 25.47, down 0.27%, last trade Fri 4:01pm Eastern.
Follow XRN
Alert me
Ratios over time Q4 FY25 to Q3 FY26
Returns on capital
ROIC was 1.40% in Q3 FY26, the lowest of these four quarters. ROE, at 10.4%, is far above it because equity is small against the capital the business uses.
| Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | |
|---|---|---|---|---|
| ROE | −2.7% | −3.5% | 10.8% | 10.4% |
| ROIC | 2.0% | 1.9% | 1.8% | 1.4% |
Debt
Net debt is 34.22× a year’s EBITDA. Debt is 0.98× equity, against 1.28× in Q1 FY26.
| Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | |
|---|---|---|---|---|
| Debt / equity | 1.2× | 1.3× | 0.9× | 1.0× |
| Net debt / EBITDA | 25.3× | 26.9× | 24.9× | 34.2× |
Per share, from Q4 FY25
Since Q4 FY25, per share: free cash flow has fallen 4.52%; revenue has grown 6.73%; book value has grown 29.7%.
| Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | |
|---|---|---|---|---|
| Free cash flow | 1.0× | 2.8× | 2.6× | 1.0× |
| Revenue | 1.0× | 1.0× | 1.0× | 1.1× |
| Book value | 1.0× | 1.0× | 1.3× | 1.3× |
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
0.00 | 0.00 | 10.09 | 9.30 |
P/S ratio |
3.05 | 2.89 | 3.24 | 2.94 | |
P/FCF ratio |
30.34 | 10.78 | 13.22 | 32.74 | |
P/Operating CF |
20.87 | 32.79 | 22.01 | 34.44 | |
P/B ratio |
1.11 | 1.10 | 1.07 | 1.00 | |
Price to Tangible BV |
1.13 | 1.12 | 1.08 | 1.01 | |
EV/Sales |
7.39 | 7.20 | 7.29 | 7.08 | |
EV/EBITDA |
11.15 | 11.11 | 11.26 | 11.82 | |
EV/Operating CF |
14.88 | 14.63 | 14.90 | 15.63 | |
EV/FCF |
73.65 | 26.90 | 29.80 | 78.85 | |
Quick Ratio |
0.61 | 0.68 | 0.59 | 0.70 | |
Current Ratio |
0.61 | 0.68 | 0.59 | 0.70 | |
Net Debt/EBITDA |
25.28 | 26.89 | 24.87 | 34.22 | |
Debt/Assets |
52.81% | 53.78% | 46.31% | 47.46% | |
Debt/Equity |
1.24 | 1.28 | 0.93 | 0.98 | |
Asset Turnover |
0.12 | 0.12 | 0.12 | 0.12 | |
Operating CF/Net income |
(2.92) | (17.83) | 0.36 | (1.51) | |
Capex/Depreciation |
0.43 | (0.14) | (2.70) | (1.14) | |
Interest Coverage |
1.12 | 1.23 | 1.05 | 0.28 | |
Selling, General and Administrative Expense of Revenue |
14.31% | 13.37% | 13.14% | 19.10% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
3.67% | 3.23% | 3.47% | 5.93% | |
Graham Net Nets |
(1.55) | (1.61) | (1.36) | (1.53) | |
Graham Number |
0.00 | 0.00 | 54.16 | 54.05 | |
Earnings Yield |
(2.67%) | (3.36%) | 9.91% | 10.75% | |
Free Cash Flow Yield |
3.30% | 9.28% | 7.56% | 3.05% | |
Revenue per Share |
2.87 | 2.88 | 3.00 | 3.05 | |
Operating CF per Share |
1.62 | 1.01 | 1.70 | 1.01 | |
Capex per Share |
0.52 | (0.16) | (3.22) | (1.43) | |
Free Cash Flow per Share |
2.13 | 0.85 | (1.51) | (0.43) | |
Cash per Share |
0.89 | 0.83 | 0.98 | 1.20 | |
Shareholders Equity per Share |
39.62 | 39.34 | 51.69 | 51.38 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
39.62 | 39.34 | 51.69 | 51.38 | |
Free Cash Flow |
28.53 | 11.21 | (20.05) | (5.63) | |
Working Capital |
(7.55) | (5.16) | (9.14) | (6.91) | |
Capital Expenditures |
6.90 | (2.14) | (42.61) | (19.00) | |
Net Current Asset Value |
(700.51) | (706.41) | (674.79) | (702.82) | |
EV/EBIT |
29.98 | 30.47 | 30.54 | 37.15 | |
Capex to Sales |
(0.18) | 0.06 | 1.07 | 0.47 | |
Price to Operating Income |
12.35 | 12.21 | 13.55 | 15.43 | |
| Other line items | |||||
Average Payables |
17.38 | 14.77 | 19.99 | 19.79 | |
Average Assets |
1,249.48 | 1,253.79 | 1,334.37 | 1,336.10 | |
Average Common Equity |
443.46 | 429.84 | 456.95 | 445.45 |